$410M
$1.2 Million
0.0% of portfolio
186,308
Q2 2025
Added 9.46%
Keen Vision Acquisition Corp
-
$0
0.0% of portfolio
-
Q3 2023
New
$496M
$5.45 Million
0.0% of portfolio
465,784
Q2 2025
Reduced 3.69%
$1.68B
$2.6 Million
0.0% of portfolio
113,329
Q2 2025
Reduced 23.79%
-
$0
0.0% of portfolio
-
Q2 2025
Added 168.85%
$16.7B
$2.42 Million
0.0% of portfolio
138,835
Q2 2025
New
$29.9B
$671,000
0.0% of portfolio
4,096
Q2 2025
Reduced 73.73%
$678M
$2.87 Million
0.0% of portfolio
69,711
Q2 2025
Added 76.53%
$515M
$2.72 Million
0.0% of portfolio
141,695
Q2 2025
Added 21.39%
Kiniksa Pharmaceuticals Intl
-
$0
0.0% of portfolio
-
Q2 2025
Added 98.95%
$4.65B
$788,000
0.0% of portfolio
34,802
Q2 2025
Reduced 39.36%
$127B
$3.47 Million
0.0% of portfolio
26,089
Q2 2025
Added 19.13%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 35.89%
$641M
$4.46 Million
0.0% of portfolio
508,960
Q2 2025
Added 25.64%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 1.3%
-
$0
0.0% of portfolio
-
Q3 2024
New
$6.87B
$226,000
0.0% of portfolio
5,118
Q2 2025
Reduced 98.49%
$1.87B
$2.76 Million
0.0% of portfolio
156,638
Q2 2025
Reduced 42.52%
$443M
$2.24 Million
0.0% of portfolio
601,629
Q2 2025
Reduced 21.71%
$1.5B
$2.03 Million
0.0% of portfolio
238,888
Q2 2025
Added 458.46%
$620M
$1.35 Million
0.0% of portfolio
41,891
Q2 2025
Reduced 59.76%
$18.1B
$1.7 Million
0.0% of portfolio
119,425
Q2 2025
Reduced 33.03%
$3.83B
$1.73 Million
0.0% of portfolio
23,591
Q2 2025
Reduced 53.45%
$756M
$5.71 Million
0.0% of portfolio
286,839
Q2 2025
Reduced 31.27%
-
$0
0.0% of portfolio
-
Q2 2025
New
$784M
$785,000
0.0% of portfolio
456,716
Q2 2025
Reduced 40.19%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 5.36%
$8.71B
$1.11 Million
0.0% of portfolio
23,913
Q2 2025
New
$554M
$817,000
0.0% of portfolio
281,038
Q2 2025
Added 30.07%
$3.69B
$1.61 Million
0.0% of portfolio
11,727
Q2 2025
Reduced 76.5%
$2.16B
$4.23 Million
0.0% of portfolio
122,233
Q2 2025
Reduced 73.49%
$415M
$811,000
0.0% of portfolio
140,713
Q2 2025
Reduced 66.42%
$690M
$3.71 Million
0.0% of portfolio
43,114
Q2 2025
New
$6.71B
$5.54 Million
0.0% of portfolio
132,065
Q2 2025
Reduced 60.71%
$1.64B
$244,000
0.0% of portfolio
6,582
Q2 2025
Reduced 95.99%
$1.42B
$2.33 Million
0.0% of portfolio
216,641
Q2 2025
Added 109.65%
$1.58B
$4.19 Million
0.0% of portfolio
68,113
Q2 2025
Added 10.33%
Lakeshore Biopharma CO LTD
-
$0
0.0% of portfolio
-
Q1 2023
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 44.89%
$10.2B
$4.74 Million
0.0% of portfolio
39,020
Q2 2025
Added 13.99%
$7.62B
$304,000
0.0% of portfolio
5,868
Q2 2025
New
$5B
$4.32 Million
0.0% of portfolio
25,018
Q2 2025
Reduced 56.83%
$439M
$1.21 Million
0.0% of portfolio
91,280
Q2 2025
Reduced 19.34%
$4.66B
$769,000
0.0% of portfolio
5,534
Q2 2025
Reduced 49.88%
Lanvin Group Holdings Limite
-
$0
0.0% of portfolio
-
Q4 2022
New
$41.2B
$1 Million
0.0% of portfolio
23,086
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
New
$861M
$906,000
0.0% of portfolio
142,152
Q2 2025
Reduced 62.52%
$8.68B
$800,000
0.0% of portfolio
16,349
Q2 2025
Added 135.2%
Launch One Acquisition Corp
-
$0
0.0% of portfolio
-
Q4 2024
Added 181.2%